Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.42 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 5/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6434905 | 0.98 | TYR (0.43) | TYRESR2NUDT1BACE1ESR1 | |
| SCHEMBL31545041 | 0.84 | CYP2C9 (0.43) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL19249421 | 0.82 | TYR (0.48) | TYRESR2CYP3A4CYP2C9 | |
| SCHEMBL6438532 | 0.81 | ESR2 (0.58) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL6438534 | 0.81 | ESR2 (0.58) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL7803551 | 0.79 | TYR (0.41) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL6436708 | 0.78 | TYR (0.45) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL7807001 | 0.78 | TYR (0.48) | TYRESR2ESR1CYP3A4CYP2C9 | |
| SCHEMBL13609950 | 0.77 | TYR (0.40) | TYRESR2CYP3A4CYP2C9 | |
| SCHEMBL6435789 | 0.76 | TYR (0.49) | TYRESR2ESR1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165495-A1 | RESORCINOL DERIVATIVES | PFIZER INC. (US) | 2002-01-02 | — | — | EP | claimed |
| WO-2000056702-A1 | RESORCINOL DERIVATIVES | PFIZER INC. (US) | 2000-09-28 | — | — | WO | claimed |
| EP-1165495-A1 | RESORCINOL DERIVATIVES | PFIZER INC. (US) | 2002-01-02 | — | — | EP | disclosed |
| EP-1134207-A1 | Process for preparing resorcinol derivatives | Pfizer Products Inc. (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000056702-A1 | RESORCINOL DERIVATIVES | PFIZER INC. (US) | 2000-09-28 | — | — | WO | disclosed |